SERNOVA BIOTHERAPEUTICS INC (SVA.CA) Stock Price, Forecast & Analysis
TSX-V:SVA • CA81752F1062
SVA.CA Key Statistics, Chart & Performance
The current stock price of SVA.CA is 0.135 CAD. In the past month the price decreased by -18.18%. In the past year, price decreased by -32.5%.
SVA.CA Technical Analysis
SVA.CA Financial Highlights
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
SVA.CA Forecast & Estimates
SVA.CA Ownership
SVA.CA Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| EPRX | EUPRAXIA PHARMACEUTICALS INC | N/A | 573.937M | ||
| EDT | SPECTRAL MEDICAL INC | N/A | 406.658M | ||
| HBP | HELIX BIOPHARMA CORP | N/A | 151.996M | ||
| MDNA | MEDICENNA THERAPEUTICS CORP | N/A | 74.235M | ||
| COV | COVALON TECHNOLOGIES LTD | 12.62 | 50.268M | ||
| BCT | BRIACELL THERAPEUTICS CORP | N/A | 38.57M | ||
| MBX | MICROBIX BIOSYSTEMS INC | 5.94 | 33.252M | ||
| RVX | RESVERLOGIX CORP | N/A | 33.069M | ||
| HEM | HEMOSTEMIX INC | N/A | 16.596M | ||
| MPH | MEDICURE INC | N/A | 9.918M |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the TSX Venture Exchange Exchange | Find stocks with similar TA and Setup ratings on the Canadian exchanges | Find stocks with similar Fundamental rating on the Canadian exchanges | Find the competitors with the best technical ratings on the Canadian exchanges | Find the competitors with the best fundamentals on the Canadian exchanges | Find the competitors with the best valuation on the Canadian exchanges | Find the competitors with the best dividend on the Canadian exchanges | Find the competitors with the best analyst ratings on the Canadian exchanges
About SVA.CA
Company Profile
Sernova Corp. is a clinical stage regenerative medicine company. The company is headquartered in London, Ontario. The firm is focused on developing and commercializing regenerative medicine therapeutics, including its Cell Pouch and associated technologies, including therapeutic cells and local cellular immune protection. The Cell Pouch is a scalable and implantable medical device. The Cell Pouch is designed to create a vascularized tissue environment for the transplantation and engraftment of therapeutic cells, which then release proteins and/or hormones for the long-term treatment of multiple chronic diseases, such as diabetes, hemophilia and thyroid disease. Its Cell Pouch combines with immune protected therapeutic cells, offers a protection from immune system attack. Its regenerative medicine therapeutic approach provides cell therapies, where the cells transplanted within an organ-like the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases.
Company Info
SERNOVA BIOTHERAPEUTICS INC
700 Collip Circle, Ste 114
London ONTARIO N6G 4X8 CA
CEO: Philip M. Toleikis
Employees: 0
Phone: 15198585126.0
SERNOVA BIOTHERAPEUTICS INC / SVA.CA FAQ
What does SERNOVA BIOTHERAPEUTICS INC do?
Sernova Corp. is a clinical stage regenerative medicine company. The company is headquartered in London, Ontario. The firm is focused on developing and commercializing regenerative medicine therapeutics, including its Cell Pouch and associated technologies, including therapeutic cells and local cellular immune protection. The Cell Pouch is a scalable and implantable medical device. The Cell Pouch is designed to create a vascularized tissue environment for the transplantation and engraftment of therapeutic cells, which then release proteins and/or hormones for the long-term treatment of multiple chronic diseases, such as diabetes, hemophilia and thyroid disease. Its Cell Pouch combines with immune protected therapeutic cells, offers a protection from immune system attack. Its regenerative medicine therapeutic approach provides cell therapies, where the cells transplanted within an organ-like the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases.
What is the current price of SVA stock?
The current stock price of SVA.CA is 0.135 CAD. The price decreased by -3.57% in the last trading session.
Does SERNOVA BIOTHERAPEUTICS INC pay dividends?
SVA.CA does not pay a dividend.
How is the ChartMill rating for SERNOVA BIOTHERAPEUTICS INC?
SVA.CA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 0 out of 10.
Which stock exchange lists SVA stock?
SVA.CA stock is listed on the TSX Venture Exchange exchange.
Can you provide the number of employees for SERNOVA BIOTHERAPEUTICS INC?
SERNOVA BIOTHERAPEUTICS INC (SVA.CA) currently has 0 employees.